A20 is a cytoplasmic zinc finger protein that inhibits nuclear factor kappa
B (NF-kappa B) activity and tumor necrosis factor (TNF)-mediated programme
d cell death (PCD). TNF dramatically increases A20 messenger RNA expression
in all tissues. Mice deficient far A20 develop severe inflammation and cac
hexia, are hypersensitive to both Lipopolysaccharide and TNF, and die prema
turely. A20-deficient cells fail to terminate TNF-induced NF-kappa B respon
ses. These cells are also more susceptible than control cells to undergo TN
F-mediated PCD. Thus, AZO is critical for limiting inflammation by terminat
ing TNF-induced NF-kappa B responses in vivo.